Evidence map›Paper›PMID 30980151›Full record

ReviewWiener klinische Wochenschrift2019

[Diabetes mellitus-Definition, classification, diagnosis, screening and prevention (Update 2019)].

Jürgen Harreiter, Michael Roden

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Wiener klinische Wochenschrift, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04222231 (Metabolic Effects of a New Resistance Training in Individuals With Type 2 Diabetes), which is not on this map. Cited by 115 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04222231 naunknown statusnot on this map

Metabolic Effects of a New Resistance Training in Individuals With Type 2 Diabetes

TypeinterventionalSponsorGerman Diabetes CenterRan2019 to 2024Enrolled24ConditionsType 2 DiabetesArmsBlood-flow restriction resistance training, Classical resistance training
3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Review
  7. Article
  8. Epigenetic regulation in a high-sugar environment (Review).International journal of molecular medicine · 2026
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jürgen HarreiterAbteilung für Endokrinologie und Stoffwechsel, Universitätsklinik für Innere Medizin III, Medizinische Universität Wien, Wien, Österreich.
Michael RodenKlinik für Endokrinologie und Diabetologie, Medizinische Fakultät, Heinrich-Heine-Universität, Düsseldorf, Deutschland. michael.roden@ddz.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus comprises a group of heterogeneous disorders, which have an increase in blood glucose concentrations in common. The current classification for diabetes mellitus is presented and the main features of type 1 and type 2 diabetes are compared. Furthermore, the criteria for the correct biochemical diagnosis during fasting and oral glucose tolerance tests as well as the use of hemoglobin A1c (HbA1c) are summarized. The increasing prevalence of diabetes requires targeted screening for detecting diabetes and prediabetes in risk groups. This forms the basis for the early initiation of measures to prevent the onset of diabetes in these risk groups and to delay the progression of diabetes.

Indexed as

Practice Guidelines as TopicPrediabetic StateBlood GlucoseDiabetes MellitusFastingGlucose Tolerance TestGlycated HemoglobinHumansTerminology as TopicBlood GlucoseGlycated HemoglobinGlucose intoleranceHyperglycemiaImpaired fasting glucoseObesityPrediabetes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.